We are live on
!
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$341M
1-Year Est. Return
20.57%
This Fund
S&P 500
This Quarter
Est. Return
+2.29%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$112M
AUM Growth
+$7.22M
(+6.9%)
Cap. Flow
+$6.17M
Cap. Flow
% of AUM
5.54%
Top 10 Holdings %
Top 10 Hldgs %
3.56%
Holding
1,843
New
512
Increased
412
Reduced
454
Closed
458
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unisys
UIS
|
+$562K |
| 2 |
Fulgent Genetics
FLGT
|
+$385K |
| 3 |
Schrodinger
SDGR
|
+$384K |
| 4 |
Agilysys
AGYS
|
+$367K |
| 5 |
Riot Platforms
RIOT
|
+$344K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NextDecade
NEXT
|
+$565K |
| 2 |
American Well
AMWL
|
+$535K |
| 3 |
iHeartMedia
IHRT
|
+$499K |
| 4 |
BRC Group Holdings
RILY
|
+$497K |
| 5 |
Lexicon Pharmaceuticals
LXRX
|
+$496K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.49% |
| 2 | Industrials | 17.12% |
| 3 | Technology | 16.79% |
| 4 | Financials | 12.57% |
| 5 | Consumer Discretionary | 12.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Ionis Pharmaceuticals
IONS
$9.35B
| $3.29K | ﹤0.01% |
76
-802
| -91% | -$38.2K |
|
1327
Mid-America Apartment Communities
MAA
$15.6B
| $3.29K | ﹤0.01% |
+25
| New | +$3.25K |
|
1328
First Citizens BancShares
FCNCA
$24.6B
| $3.27K | ﹤0.01% |
2
-35
| -95% | -$52.6K |
|
1329
LXP Industrial Trust
LXP
$3.53B
| $3.19K | ﹤0.01% |
71
+4
| +6% | +$182 |
|
1330
Recursion Pharmaceuticals
RXRX
$1.57B
| $3.13K | ﹤0.01% |
314
-529
| -63% | -$5.89K |
|
1331
Kearny Financial
KRNY
$592M
| $3.1K | ﹤0.01% |
481
-7,400
| -94% | -$51.8K |
|
1332
Veeco
VECO
$3.15B
| $3.06K | ﹤0.01% |
+87
| New | +$2.9K |
|
1333
Travelers Companies
TRV
$80.8B
| $2.99K | ﹤0.01% |
+13
| New | +$2.78K |
|
1334
DoubleVerify
DV
$1.62B
| $2.95K | ﹤0.01% |
84
-599
| -88% | -$22.3K |
|
1335
Hims & Hers Health
HIMS
$6.5B
| $2.68K | ﹤0.01% |
173
-6,263
| -97% | -$70.6K |
|
1336
BlackRock TCP Capital
TCPC
$265M
| $2.67K | ﹤0.01% |
256
-1,857
| -88% | -$20.5K |
|
1337
PLDT
PHI
$4.25B
| $2.54K | ﹤0.01% |
103
-1,411
| -93% | -$33K |
|
|
HIBB
1338
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $2.38K | ﹤0.01% |
31
+1
| +3% | +$72 |
|
1339
Lloyds Banking Group
LYG
$87.4B
| $2.24K | ﹤0.01% |
+866
| New | +$1.99K |
|
1340
Liberty Broadband Class A
LBRDA
$4.14B
| $2.11K | ﹤0.01% |
+37
| New | +$2.44K |
|
|
AMK
1341
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $2.09K | ﹤0.01% |
59
-2,010
| -97% | -$65.7K |
|
1342
Amazon
AMZN
$2.5T
| $1.98K | ﹤0.01% |
11
-32
| -74% | -$5.34K |
|
1343
Relay Therapeutics
RLAY
$4.02B
| $1.92K | ﹤0.01% |
+231
| New | +$2.25K |
|
1344
Liberty Global Class C
LBTYK
$3.27B
| $1.8K | ﹤0.01% |
+102
| New | +$1.96K |
|
|
DOCU
1345
DocuSign
DOCU
$9.63B
| $1.79K | ﹤0.01% |
30
-728
| -96% | -$41.1K |
|
1346
IQVIA
IQV
$34.7B
| $1.77K | ﹤0.01% |
7
-89
| -93% | -$20.8K |
|
1347
Planet Labs
PL
$7.3B
| $1.72K | ﹤0.01% |
675
-12,417
| -95% | -$28.1K |
|
1348
Markel Group
MKL
$25B
| $1.52K | ﹤0.01% |
+1
| New | +$1.47K |
|
|
CWEN.A
1349
DELISTED
Clearway Energy Class A
CWEN.A
| $1.51K | ﹤0.01% |
70
+5
| +8% | +$109 |
|
1350
Pearson
PSO
$9.78B
| $1.42K | ﹤0.01% |
+108
| New | +$1.34K |
|
Similar funds
SFA
FCM
CPI
SW
MTIC
KFSC
YCM
SC
EntryPoint Capital's Q1 2024 Portfolio in Review
As of Q1 2024, EntryPoint Capital held 1,843 positions worth $112M, up 6.9% from $104M the previous quarter. Its ten largest holdings account for 3.6% of the portfolio.
EntryPoint Capital deployed $6.17M of net new capital in Q1 2024, opening 512 new positions and adding to 412 existing holdings. Its largest new stake was Unisys: 92,556 shares worth $454K.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was NextDecade, an estimated $565K trimmed.
- EntryPoint Capital's largest Q1 2024 buy was Unisys: 92,556 shares worth $454K.
- EntryPoint Capital added most to Fulgent Genetics in Q1 2024, an estimated $385K increase.
- EntryPoint Capital's biggest Q1 2024 reduction was NextDecade, cutting an estimated $565K.
- EntryPoint Capital fully exited American Well in Q1 2024, selling an estimated $535K.
- EntryPoint Capital's ten largest holdings make up 3.6% of its $112M portfolio in Q1 2024.
- EntryPoint Capital opened 512 new positions and closed 458 in Q1 2024.
- EntryPoint Capital's portfolio value rose 6.9% quarter-over-quarter to $112M.
Based on EntryPoint Capital's 13F filing for Q1 2024, filed 14 May 2024.